<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03913364</url>
  </required_header>
  <id_info>
    <org_study_id>UChile-Bifidice-1</org_study_id>
    <nct_id>NCT03913364</nct_id>
  </id_info>
  <brief_title>Impact of B. Bifidum 900791 Intake on Breast Milk Characteristics of Obese Mothers</brief_title>
  <official_title>Evaluation of B. Bifidum 900791 as a Modulator of Microbiota, Inflammatory Mediators and Metabolic Hormones in Breast Milk From Obese Mothers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chile</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chile</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Human breast milk harbours a specific microbiota including bacteria from the Lactobacillus
      and Bifidobacterium genera, that contribute to the bacterial colonization of the infant gut
      in the post-natal period. An entero-mammary pathway has been suggested by which selected
      bacteria from the maternal gut would be transmitted to the mammary gland through dendritic
      cell trafficking by the lymphatic pathway. Accordingly, some studies have detected the
      presence of probiotic strains in breast milk from mothers who were consuming them. The
      administration of probiotic supplements to lactating mothers has also been shown to modulate
      milk concentrations of inflammatory markers and metabolic hormones, impacting positively the
      infant health. Noteworthily, many of these inflammatory and hormonal biomarkers are altered
      in the breastmilk from pre-pregnancy obese mothers, compared with these who were
      normal-weight, possibly affecting the infant health. It is unclear whether the breast milk
      microbiota of obese mothers is altered and the impact of probiotic administration on the
      breastmilk microbiota and on the normalization of breastmilk alterations in obese mothers is
      unknown.

      Based on these antecedents, the aim of this study is to determine if the administration of a
      B. bifidum 900791-containing foodstuff to mothers during the perinatal period normalizes the
      breast milk concentrations of interleukin (IL)-6, C-Reactive Protein (CRP), insulin,
      adiponectin and resistin, and the microbiota of obese mothers, compared with normal-weight
      mothers.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Obese mothers and normal-weight mothers will each be randomized in two groups to receive the probiotic product or the placebo. Colostrum and breastmilk samples will obtained at days 2 and 30 post-partum, respectively, and infant fecal samples at day 30.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>C-Reactive Protein concentration in breastmilk</measure>
    <time_frame>Day-30</time_frame>
    <description>Concentration of CRP in breastmilk</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>IL-6 concentration in breastmilk</measure>
    <time_frame>Day 30</time_frame>
    <description>Concentration of IL-6 in breastmilk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin concentration in breastmilk</measure>
    <time_frame>Day 30</time_frame>
    <description>Concentration of Insulin in breastmilk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resistin concentration in breastmilk</measure>
    <time_frame>Day 30</time_frame>
    <description>Concentration of resistin in breastmilk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adiponectin concentration in breastmilk</measure>
    <time_frame>Day 30</time_frame>
    <description>Concentration of adiponectin in breastmilk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Milk microbiota diversity</measure>
    <time_frame>Day 30</time_frame>
    <description>Intra-and Interindividual diversity of the milk microbiota</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Milk microbiota composition</measure>
    <time_frame>Day 30</time_frame>
    <description>Relative abundancies of the different bacterial taxa detected by high throughput sequencing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of B. bifidum 900791 in breastmilk</measure>
    <time_frame>Day 30</time_frame>
    <description>Presence of the probiotic strain B. bifidum 900791 in breastmilk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant fecal microbiota diversity</measure>
    <time_frame>Day 30</time_frame>
    <description>Intra-and Interindividual diversity of the infant fecal microbiota</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant fecal microbiota composition</measure>
    <time_frame>Day 30</time_frame>
    <description>Relative abundancies of the different bacterial taxa detected by high throughput sequencing</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Colostrum IL-6</measure>
    <time_frame>Day 2</time_frame>
    <description>Concentrations of IL-6 in colostrum</description>
  </other_outcome>
  <other_outcome>
    <measure>Colostrum CRP</measure>
    <time_frame>Day 2</time_frame>
    <description>Concentrations of CRP in colostrum</description>
  </other_outcome>
  <other_outcome>
    <measure>Colostrum insulin</measure>
    <time_frame>Day 2</time_frame>
    <description>Concentrations of insulin in colostrum</description>
  </other_outcome>
  <other_outcome>
    <measure>Colostrum resistin</measure>
    <time_frame>Day 2</time_frame>
    <description>Concentrations of resistin in colostrum</description>
  </other_outcome>
  <other_outcome>
    <measure>Colostrum adiponectin</measure>
    <time_frame>Day 2</time_frame>
    <description>Concentrations of adiponectin in colostrum</description>
  </other_outcome>
  <other_outcome>
    <measure>Colostrum microbiota diversity</measure>
    <time_frame>Day 2</time_frame>
    <description>Intra-and Interindividual diversity of colostrum</description>
  </other_outcome>
  <other_outcome>
    <measure>Presence of the probiotic strain in colostrum</measure>
    <time_frame>Day 2</time_frame>
    <description>Presence of the probiotic strain B. bifidum 900791 in colostrum</description>
  </other_outcome>
  <other_outcome>
    <measure>Colostrum microbiota composition</measure>
    <time_frame>Day 2</time_frame>
    <description>Relative abundancies of the different bacterial taxa detected by high throughput sequencing</description>
  </other_outcome>
  <other_outcome>
    <measure>Presence of mastitis</measure>
    <time_frame>Days 0-30 pp.</time_frame>
    <description>Presence of mastitis in the mother during the first month post-partum</description>
  </other_outcome>
  <other_outcome>
    <measure>Presence of infant colic</measure>
    <time_frame>Days 0-30 pp.</time_frame>
    <description>Appearance of colic in the infant during the first month post-partum</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Maternal Obesity</condition>
  <arm_group>
    <arm_group_label>Experimental Obese mothers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One portion (50g) of an ice-cream containing the probiotic B. bifidum 900791 (&gt;10(exp7)/g) every other day during the last month of gestation and the first month of lactation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Obese mothers</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>One portion (50g) of an ice-cream without probiotic every other day during the last month of gestation and the first month of lactation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental normal weight mothers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One portion (50g) of an ice-cream containing B. bifidum 900791 (&gt;10(exp7)/g) every other day during the last month of gestation and the first month of lactation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo normal weight mothers</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>One portion (50g) of an ice-cream without probiotic every other day during the last month of gestation and the first month of lactation</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotic</intervention_name>
    <description>B. bifidum 900791-containing ice cream</description>
    <arm_group_label>Experimental Obese mothers</arm_group_label>
    <arm_group_label>Experimental normal weight mothers</arm_group_label>
    <other_name>Bifidice</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo ice-cream</description>
    <arm_group_label>Placebo Obese mothers</arm_group_label>
    <arm_group_label>Placebo normal weight mothers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women in their last month of pregnancy, who were normal-weight (18.5&lt;BMI&lt;25kg/m2) or
             who were obese (BMI&gt;30kg/m2) before pregnancy, and their children

        Women recruited should have expressed their wish to have their child through normal
        delivery, and to breastfeed at least during the first month post-partum.

        Exclusion Criteria:

          -  Women with chronic diseases (type 2 diabetes, renal diseases, autoimmune diseases,
             tumor, chronic inflammatory diseases, etc.).

          -  Women with a history of digestive surgery.

          -  Women whose children are hospitalized more than 24hours in the neonatal unit

          -  Women who require antibiotic treatment during the perinatal period.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cynthia Barrera, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univ. of Chile</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fabien Magne, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chile</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin Gotteland, PhD</last_name>
    <phone>56-2-29786977</phone>
    <email>mgottela@med.uchile.cl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carvajal Bielka, RM, MaSc</last_name>
    <phone>56-2-29786611</phone>
    <email>bielka.carvajal@gmail.com</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Martín R, Langa S, Reviriego C, Jimínez E, Marín ML, Xaus J, Fernández L, Rodríguez JM. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr. 2003 Dec;143(6):754-8.</citation>
    <PMID>14657823</PMID>
  </results_reference>
  <results_reference>
    <citation>Qian L, Song H, Cai W. Determination of Bifidobacterium and Lactobacillus in breast milk of healthy women by digital PCR. Benef Microbes. 2016 Sep;7(4):559-69. doi: 10.3920/BM2015.0195. Epub 2016 May 31.</citation>
    <PMID>27241905</PMID>
  </results_reference>
  <results_reference>
    <citation>Jiménez E, Fernández L, Maldonado A, Martín R, Olivares M, Xaus J, Rodríguez JM. Oral administration of Lactobacillus strains isolated from breast milk as an alternative for the treatment of infectious mastitis during lactation. Appl Environ Microbiol. 2008 Aug;74(15):4650-5. doi: 10.1128/AEM.02599-07. Epub 2008 Jun 6.</citation>
    <PMID>18539795</PMID>
  </results_reference>
  <results_reference>
    <citation>Abrahamsson TR, Sinkiewicz G, Jakobsson T, Fredrikson M, Björkstén B. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. J Pediatr Gastroenterol Nutr. 2009 Sep;49(3):349-54. doi: 10.1097/MPG.0b013e31818f091b.</citation>
    <PMID>19525871</PMID>
  </results_reference>
  <results_reference>
    <citation>Dubos C, Vega N, Carvallo C, Navarrete P, Cerda C, Brunser O, Gotteland M. Identification of Lactobacillus spp. in colostrum from Chilean mothers. Arch Latinoam Nutr. 2011 Mar;61(1):66-8.</citation>
    <PMID>22097291</PMID>
  </results_reference>
  <results_reference>
    <citation>Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr. 2012 Sep;96(3):544-51. doi: 10.3945/ajcn.112.037382. Epub 2012 Jul 25.</citation>
    <PMID>22836031</PMID>
  </results_reference>
  <results_reference>
    <citation>Rautava S. Probiotic Intervention Through the Pregnant and Breastfeeding Mother to Reduce Disease Risk in the Child. Breastfeed Med. 2018 Apr;13(S1):S14-S15. doi: 10.1089/bfm.2018.29076.sjr.</citation>
    <PMID>29624429</PMID>
  </results_reference>
  <results_reference>
    <citation>Luoto R, Laitinen K, Nermes M, Isolauri E. Impact of maternal probiotic-supplemented dietary counseling during pregnancy on colostrum adiponectin concentration: a prospective, randomized, placebo-controlled study. Early Hum Dev. 2012 Jun;88(6):339-44. doi: 10.1016/j.earlhumdev.2011.09.006. Epub 2011 Sep 25.</citation>
    <PMID>21945174</PMID>
  </results_reference>
  <results_reference>
    <citation>Savino F, Fissore MF, Liguori SA, Oggero R. Can hormones contained in mothers' milk account for the beneficial effect of breast-feeding on obesity in children? Clin Endocrinol (Oxf). 2009 Dec;71(6):757-65. doi: 10.1111/j.1365-2265.2009.03585.x. Epub 2009 Mar 19. Review.</citation>
    <PMID>19302580</PMID>
  </results_reference>
  <results_reference>
    <citation>Andreas NJ, Hyde MJ, Herbert BR, Jeffries S, Santhakumaran S, Mandalia S, Holmes E, Modi N. Impact of maternal BMI and sampling strategy on the concentration of leptin, insulin, ghrelin and resistin in breast milk across a single feed: a longitudinal cohort study. BMJ Open. 2016 Jul 7;6(7):e010778. doi: 10.1136/bmjopen-2015-010778.</citation>
    <PMID>27388351</PMID>
  </results_reference>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>April 8, 2019</study_first_submitted>
  <study_first_submitted_qc>April 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2019</study_first_posted>
  <last_update_submitted>May 28, 2019</last_update_submitted>
  <last_update_submitted_qc>May 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Chile</investigator_affiliation>
    <investigator_full_name>Martin Gotteland</investigator_full_name>
    <investigator_title>Head, Lab. of Digestive physiology</investigator_title>
  </responsible_party>
  <keyword>obesity</keyword>
  <keyword>breast milk</keyword>
  <keyword>probiotic</keyword>
  <keyword>IL-6</keyword>
  <keyword>CRP</keyword>
  <keyword>Insulin</keyword>
  <keyword>Adiponectin</keyword>
  <keyword>Resistin</keyword>
  <keyword>breastmilk microbiota</keyword>
  <keyword>Bifidobacterium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

